The OEM Business Unit is responsible for supporting our business-to-business partners with a multi-product portfolio that is globally competitive, and comprises our protected intellectual property, technology and knowhow.
Unlike many of our competitors, we offer a full design, development, manufacture and distribution service supported by regulatory, clinical and marketing professionals. We partner with many of the world’s leading healthcare companies for the supply of their finished packed products.
Our advanced wound care platform technologies include alginates, foams, fibres, collagens, hydrogels and hydrocolloids. We are also able to add antimicrobials, such as silver and PHMB, to our platform technologies. We are able to support our partners to access new markets through our regulatory expertise.
This Business Unit is responsible for the R&D activities for our advanced wound care product range and associated technologies.